SMS Pharmaceuticals Limited (SMSPHARMA.BO)

INR 242.45

(2.08%)

Inventory Summary of SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited's latest annual inventory in 2023 was 2.33 Billion INR , up 4.56% from previous year.
SMS Pharmaceuticals Limited's latest quarterly inventory in 2023 FY was 2.33 Billion INR , up 4.56% from previous quarter.
SMS Pharmaceuticals Limited reported annual inventory of 2.23 Billion INR in 2022, down -10.99% from previous year.
SMS Pharmaceuticals Limited reported annual inventory of 2.51 Billion INR in 2021, up 82.24% from previous year.
SMS Pharmaceuticals Limited reported quarterly inventory of - INR for 2023 Q3, down -100.0% from previous quarter.
SMS Pharmaceuticals Limited reported quarterly inventory of 2.77 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of SMS Pharmaceuticals Limited (2023 - 2004)

Historical Annual Inventory of SMS Pharmaceuticals Limited (2023 - 2004)

Year	Inventory	Inventory Growth
2023	2.33 Billion INR	4.56%
2022	2.23 Billion INR	-10.99%
2021	2.51 Billion INR	82.24%
2020	1.37 Billion INR	6.65%
2019	1.29 Billion INR	-5.28%
2018	1.36 Billion INR	26.91%
2017	1.07 Billion INR	16.17%
2016	925.19 Million INR	30.59%
2015	708.48 Million INR	-17.64%
2014	860.2 Million INR	-4.92%
2013	904.73 Million INR	-13.86%
2012	1.05 Billion INR	-23.94%
2011	1.38 Billion INR	20.68%
2010	1.14 Billion INR	51.01%
2009	757.7 Million INR	5.34%
2008	719.26 Million INR	13.18%
2007	635.51 Million INR	61.39%
2006	393.77 Million INR	48.02%
2005	266.02 Million INR	15.69%
2004	229.94 Million INR	0.0%

Year	Inventory	Inventory Growth
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	2.77 Billion INR	0.0%
2023 FY	2.33 Billion INR	4.56%
2023 Q4	2.33 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	2.23 Billion INR	0.0%
2022 FY	2.23 Billion INR	-10.99%
2022 Q1	- INR	-100.0%
2022 Q2	2.61 Billion INR	0.0%
2021 Q4	2.51 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q2	2.22 Billion INR	0.0%
2021 FY	2.51 Billion INR	82.24%
2020 Q2	1.43 Billion INR	0.0%
2020 FY	1.37 Billion INR	6.65%
2020 Q4	1.37 Billion INR	0.0%
2019 FY	1.29 Billion INR	-5.28%
2019 Q2	1.19 Billion INR	0.0%
2019 Q4	1.29 Billion INR	0.0%
2018 FY	1.36 Billion INR	26.91%
2018 Q4	1.36 Billion INR	0.0%
2017 FY	1.07 Billion INR	16.17%
2016 Q2	1.04 Billion INR	0.0%
2016 FY	925.19 Million INR	30.59%
2015 Q4	708.48 Million INR	0.0%
2015 FY	708.48 Million INR	-17.64%
2015 Q2	933.46 Million INR	0.0%
2014 Q4	860.2 Million INR	0.0%
2014 Q2	870.66 Million INR	0.0%
2014 FY	860.2 Million INR	-4.92%
2013 Q4	904.73 Million INR	0.0%
2013 FY	904.73 Million INR	-13.86%
2013 Q2	931.28 Million INR	0.0%
2012 FY	1.05 Billion INR	-23.94%
2012 Q4	1.05 Billion INR	0.0%
2011 FY	1.38 Billion INR	20.68%
2011 Q4	1.38 Billion INR	0.0%
2010 FY	1.14 Billion INR	51.01%
2009 FY	757.7 Million INR	5.34%
2008 FY	719.26 Million INR	13.18%
2007 FY	635.51 Million INR	61.39%
2006 FY	393.77 Million INR	48.02%
2005 FY	266.02 Million INR	15.69%
2004 FY	229.94 Million INR	0.0%

Peer Inventory Comparison of SMS Pharmaceuticals Limited

Name	Inventory	Inventory Difference
Abbott India Limited	6.19 Billion INR	62.281%
Cipla Limited	52.37 Billion INR	95.538%
Gland Pharma Limited	16.55 Billion INR	85.881%
GlaxoSmithKline Pharmaceuticals Limited	5.33 Billion INR	56.229%
Kopran Limited	1.38 Billion INR	-68.752%
Marksans Pharma Limited	6.17 Billion INR	62.181%
NGL Fine-Chem Limited	433.03 Million INR	-439.675%
Pfizer Limited	4.33 Billion INR	46.114%
Sanofi India Limited	6.63 Billion INR	64.794%